Medical News

Results of the highly anticipated ISCHEMIA trial presented at the American Heart Association (AHA) 2019 Scientific ... read more
Apabetalone demonstrated tolerability and safety in the phase 3 BETonMACE trial but the study did not ... read more
Results of the phase 3 ORION-10 study examining the effects of inclisiran on elevated LDL-C in ... read more
While it is unknown whether hypertension causes sleep apnea or vice versa, it is well-documented that ... read more
Results of a new study have revealed colchicine, an anti-inflammatory with indications for conditions including gout ... read more
This morning at the American Heart Association (AHA) 2019 Scientific Sessions in Philadelphia, Janssen Pharmaceutical Companies ... read more
Findings from the massive Apple Heart Study show one-third of participants to be notified of an ... read more
Lumasiran, a subcutaneously-administered investigational RNAi therapeutic specially designed to decrease oxalate production, could treat patients with ... read more